Inovio Pharmaceuticals
INO
INO
125 hedge funds and large institutions have $196M invested in Inovio Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 34 increasing their positions, 38 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 38
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
Holders
125
Holding in Top 10
–
Calls
$6.66M
Puts
$4.66M
Top Buyers
| 1 | +$4.42M | |
| 2 | +$2.24M | |
| 3 | +$1.43M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.37M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.19M |
Top Sellers
| 1 | -$1.45M | |
| 2 | -$1.28M | |
| 3 | -$968K | |
| 4 |
GC
Globeflex Capital
San Diego,
California
|
-$928K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$918K |